Private Wealth Partners’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-4,000
Closed -$290K 82
2020
Q4
$290K Buy
+4,000
New +$232K 0.03% 101
2020
Q3
Sell
-6,000
Closed -$213K 119
2020
Q2
$213K Buy
+6,000
New +$171K 0.03% 99
2019
Q3
Sell
-6,000
Closed -$216K 127
2019
Q2
$216K Buy
+6,000
New +$192K 0.03% 122
2018
Q4
Sell
-281,000
Closed -$8.11M 101
2018
Q3
$8.11M Sell
281,000
-27,000
-9% -$505K 1.24% 26
2018
Q2
$3.77M Sell
308,000
-626,500
-67% -$7.18M 0.63% 46
2018
Q1
$7.45M Buy
934,500
+498,500
+114% +$3.07M 1.3% 26
2017
Q4
$3.2M Buy
436,000
+201,000
+86% +$1.25M 0.59% 51
2017
Q3
$869K Buy
235,000
+225,000
+2,250% +$473K 0.17% 80
2017
Q2
$11K Buy
+10,000
New +$10.6K ﹤0.01% 112

Other funds holding CDNA

Private Wealth Partners's CDNA Position: Q1 2021 in Review

Private Wealth Partners sold out of CareDx (CDNA) in Q1 2021, closing a stake of 4,000 shares — an estimated $290K sold.

Private Wealth Partners first reported a position in CDNA in Q2 2017 and held it in 9 quarters. The position peaked at $8.11M in Q3 2018. 245 funds tracked by Wall St. Rank hold CDNA as of Q1 2021.

  • Private Wealth Partners reported no remaining CareDx position as of Q1 2021 after selling out during the quarter.
  • Private Wealth Partners sold 4,000 CareDx shares in Q1 2021, an estimated $290K.
  • Private Wealth Partners first reported a position in CareDx in Q2 2017 and held it in 9 quarters.
  • Private Wealth Partners's CareDx position peaked at $8.11M in Q3 2018.
  • 245 funds tracked by Wall St. Rank held CareDx as of Q1 2021.

Based on Private Wealth Partners's 13F filing for Q1 2021, filed 4 May 2021.